BENESTERMYCIN (20+56+20)MG/ML ενδομαστικό εναιώρημα
BENESTERMYCIN (20+56+20)MG/ML ενδομαστικό εναιώρημα
Viðurkennt
- Penethamate hydriodide
- Benethamine penicillin
- Framycetin sulfate
Auðkenning lyfsins
Upplýsingar um lyfið
Lyfjaform:
-
Spenalyf, dreifa
Withdrawal period by route of administration:
-
Til notkunar í spena
- Nautgripir (kýr)
-
Kjöt og innmatur9dagar
-
Mjólk36klukkustundirεάν χορηγηθεί τουλάχιστον 35 ημέρες πριν από τον τοκετό
-
Mjólk37dagarεάν χορηγηθεί σε διάστημα μικρότερο από 35 ημέρες πριν από τον τοκετό
-
ATC flokkun (dýralyf):
- QJ51RC25
Lögformleg staða:
-
Ávísunarskylt dýralyf
Staða markaðsleyfis:
-
Gilt
Authorised in:
-
Grikkland
Available in:
-
Grikkland
Áletrun:
- Aðeins í boði í Greek
Viðbótarupplýsingar
Entitlement type:
-
Marketing Authorisation
Markaðsleyfishafi:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Framleiðandi sem ber ábyrgð á lokasamþykkt:
- Lohmann Pharma Herstellung GmbH
- Haupt Pharma Latina S.r.l.
Ábyrgt yfirvald:
- National Organization For Medicines
Markaðsleyfisnúmer:
- 18393/04-06-2013/Κ-0096801
Dagsetning leyfisbreytingar:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Hversu gagnlegt var þessi síða?: